Beam Therapeutics vs Emendo Biotherapeutics
Beam Therapeutics vs Emendo Biotherapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Beam Therapeutics is on 47/100 and Emendo Biotherapeutics on 59/100.
Where each one leads
Beam Therapeutics
- funding raised: $235M against $61.0M
Emendo Biotherapeutics
- our overall score: 59/100 against 47/100
- domain rating: 20/100 against 0/100
At a glance
| Measure | Beam Therapeutics | Emendo Biotherapeutics |
|---|---|---|
| What it is | A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases. | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. |
| Category | Workflows, Biotech, MedTech, Genomics | Healthcare, Genome Editing, CRISPR, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2015 |
| Headquarters | Cambridge, United States | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Beam Therapeutics | Emendo Biotherapeutics |
|---|---|---|
| Employees | Not published | 41 |
| Headcount growthLast 12 months | Not published | -16.1% |
| Total funding | $235M | $61.0M |
| Latest round | Series C | Series B |
| LinkedIn followers | Not published | 5,333 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Beam Therapeutics | Emendo Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 59/100 |
| Traction | 40/100 | 55/100 |
| Team | Not published | 40/100 |
| Search visibility | 2/100 | 44/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (40/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 20/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Beam Therapeutics | Emendo Biotherapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Beam Therapeutics vs Emendo Biotherapeutics: common questions
Which is better, Beam Therapeutics or Emendo Biotherapeutics?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Beam Therapeutics and Emendo Biotherapeutics compare on the numbers?
Beam Therapeutics leads on funding raised ($235M against $61.0M). Emendo Biotherapeutics leads on our overall score (59/100 against 47/100), domain rating (20/100 against 0/100).
Read the full Beam Therapeutics review and pricing or the Emendo Biotherapeutics review and pricing. You can also browse other Beam Therapeutics alternatives we track.